•
Dec 31, 2024

ORIC Pharmaceuticals Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$0.52
6.1% YoY
Total Revenue
$0
Previous year: $1.54M
-100.0%
Gross Profit
-$304K
Previous year: $1.28M
-123.8%
Cash and Equivalents
$256M
Previous year: $235M
+8.9%
Free Cash Flow
-$28.3M
Previous year: -$24.6M
+15.1%
Total Assets
$277M
Previous year: $255M
+8.7%

ORIC Pharmaceuticals

ORIC Pharmaceuticals